220 related articles for article (PubMed ID: 30676208)
1. A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities.
Mittal N; Davidson J; Martinez MF; Sanchez R; Sane N; Giordano L; Choi DK; Kent P; Dighe D; Iqbal A; Kiely C; Breen K; Quigley JG; Catchatourian R; Gitelis S; Schmidt ML
J Adolesc Young Adult Oncol; 2019 Jun; 8(3):227-235. PubMed ID: 30676208
[No Abstract] [Full Text] [Related]
2. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
Roth ME; O'Mara AM; Seibel NL; Dickens DS; Langevin AM; Pollock BH; Freyer DR
J Oncol Pract; 2016 Apr; 12(4):e388-95. PubMed ID: 27026648
[TBL] [Abstract][Full Text] [Related]
3. The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.
Roth M; Mittal N; Saha A; Freyer DR
J Adolesc Young Adult Oncol; 2020 Aug; 9(4):522-527. PubMed ID: 32077782
[No Abstract] [Full Text] [Related]
4. Attendance at National Cancer Institute and Children's Oncology Group Facilities for Children, Adolescents, and Young Adults with Cancer in Pennsylvania: A Population-Based Study.
Rao P; Segel JE; McGregor LM; Lengerich EJ; Drabick JJ; Miller B
J Adolesc Young Adult Oncol; 2020 Feb; 9(1):47-54. PubMed ID: 31600095
[No Abstract] [Full Text] [Related]
5. Utilization of Teleconsent for Adolescent and Young Adult Cancer Clinical Trials, a Report from the Children's Oncology Group.
Terao M; Mittal N; Roth M; Saha A; Super L; Reichek J
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):132-137. PubMed ID: 37540127
[No Abstract] [Full Text] [Related]
6. Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.
Winestone LE; Beauchemin MP; Bona K; Kahn J; Prasad P; Robles JM; Velez MC;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30592. PubMed ID: 37501542
[TBL] [Abstract][Full Text] [Related]
7. Loss to follow-up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group.
Puthenpura V; Ji L; Xu X; Roth ME; Freyer DR; Frazier AL; Marks AM; Pashankar FD
Cancer; 2023 May; 129(10):1547-1556. PubMed ID: 36813754
[TBL] [Abstract][Full Text] [Related]
8. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
[TBL] [Abstract][Full Text] [Related]
9. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
[TBL] [Abstract][Full Text] [Related]
10. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
[TBL] [Abstract][Full Text] [Related]
11. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
[No Abstract] [Full Text] [Related]
12. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
Alvarez E; Keegan T; Johnston EE; Haile R; Sanders L; Saynina O; Chamberlain LJ
Cancer; 2017 Jul; 123(13):2516-2523. PubMed ID: 28241089
[TBL] [Abstract][Full Text] [Related]
13. Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.
Collins CL; Malvar J; Hamilton AS; Deapen DM; Freyer DR
Cancer; 2015 Dec; 121(24):4398-406. PubMed ID: 26393950
[TBL] [Abstract][Full Text] [Related]
14. Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.
Faulk KE; Anderson-Mellies A; Cockburn M; Green AL
PLoS One; 2020; 15(4):e0230824. PubMed ID: 32324751
[TBL] [Abstract][Full Text] [Related]
15. Accrual Trends for Children's Oncology Group Clinical Trials: A Single Center Experience.
Anderson B; Wolfe I; Muruganand A; Mody R
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e546-e550. PubMed ID: 32976351
[TBL] [Abstract][Full Text] [Related]
16. Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Rosenberg SM; McCue S; He J; Lafky JM; Carey LA; Galanis E; Leonard JP; Meyerhardt J; Ng K; Schwartz GK; Stock W; Paskett ED; Partridge AH; George S
Cancer; 2024 Mar; 130(5):750-769. PubMed ID: 37916800
[TBL] [Abstract][Full Text] [Related]
17. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
[TBL] [Abstract][Full Text] [Related]
18. Improved access and quality of care after enrollment in the New York State Children's Health Insurance Program (SCHIP).
Szilagyi PG; Dick AW; Klein JD; Shone LP; Zwanziger J; McInerny T
Pediatrics; 2004 May; 113(5):e395-404. PubMed ID: 15121980
[TBL] [Abstract][Full Text] [Related]
19. Impact of treatment site in adolescents and young adults with central nervous system tumors.
Wolfson J; Sun CL; Kang T; Wyatt L; D'Appuzzo M; Bhatia S
J Natl Cancer Inst; 2014 Aug; 106(8):dju166. PubMed ID: 25178694
[TBL] [Abstract][Full Text] [Related]
20. Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology.
Roth ME; Grimes AC; Reed DR; Weiss AR; Mittal N; Parsons SK; Freyer DR;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30564. PubMed ID: 37439574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
